Apremilast
Common brands: Otezla, Methotrexate, Rasuvo, Otrexup, Trexall
Top reporter: Amgen, Inc
Phosphodiesterase 4 Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Folate Analog Metabolic Inhibitor [EPC]Tumor Necrosis Factor Blocker [EPC]
144,030
Total Reports
29,889
Serious Reports
5,673
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (3.94%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Apremilast.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DIARRHOEA | 24,445 | |
| 2 | NAUSEA | 22,018 | |
| 3 | PSORIASIS | 20,366 | |
| 4 | HEADACHE | 17,784 | |
| 5 | DRUG INEFFECTIVE | 15,439 | |
| 6 | ABDOMINAL DISCOMFORT | 8,145 | |
| 7 | PSORIATIC ARTHROPATHY | 7,958 | |
| 8 | PAIN | 6,733 | |
| 9 | RASH | 6,607 | |
| 10 | VOMITING | 6,427 | |
| 11 | ARTHRALGIA | 6,317 | |
| 12 | FATIGUE | 6,112 | |
| 13 | DEPRESSION | 5,488 | |
| 14 | OFF LABEL USE | 5,148 | |
| 15 | WEIGHT DECREASED | 4,992 | |
| 16 | ABDOMINAL PAIN UPPER | 4,823 | |
| 17 | PRODUCT DOSE OMISSION ISSUE | 4,767 | |
| 18 | PRODUCT DOSE OMISSION | 4,594 | |
| 19 | MALAISE | 4,558 | |
| 20 | PRURITUS | 4,225 | |
| 21 | DECREASED APPETITE | 3,823 | |
| 22 | CONDITION AGGRAVATED | 3,774 | |
| 23 | THERAPY NON-RESPONDER | 3,726 | |
| 24 | DIZZINESS | 3,380 | |
| 25 | INSOMNIA | 3,322 | |
| 26 | JOINT SWELLING | 3,311 | |
| 27 | ADVERSE DRUG REACTION | 3,309 | |
| 28 | NASOPHARYNGITIS | 3,278 | |
| 29 | ALOPECIA | 3,248 | |
| 30 | RHEUMATOID ARTHRITIS | 3,239 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.